A detailed history of Alpha Centric Advisors LLC transactions in Inari Medical, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 15,000 shares of NARI stock, worth $625,200. This represents 0.6% of its overall portfolio holdings.

Number of Shares
15,000
Previous 63,000 76.19%
Holding current value
$625,200
Previous $3.02 Million 76.11%
% of portfolio
0.6%
Previous 2.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$37.11 - $50.69 $1.78 Million - $2.43 Million
-48,000 Reduced 76.19%
15,000 $722,000
Q1 2024

Apr 24, 2024

BUY
$40.65 - $65.76 $2.36 Million - $3.81 Million
58,000 Added 1160.0%
63,000 $3.02 Million
Q4 2023

Feb 14, 2024

BUY
$48.3 - $68.06 $241,500 - $340,300
5,000 New
5,000 $324,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.23B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.